Literature DB >> 24829232

Diarrhea burden due to natural infection with enterotoxigenic Escherichia coli in a birth cohort in a rural Egyptian community.

A Mansour1, H I Shaheen2, M Amine3, K Hassan2, J W Sanders2, M S Riddle2, A W Armstrong2, A M Svennerholm4, P J Sebeny2, J D Klena2, S Y N Young2, R W Frenck2.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) is commonly associated with diarrhea in Egyptian children. Children less than 3 years old in Abu Homos, Egypt, had approximately five diarrheal episodes per child every year, and at least one of these episodes was due to ETEC. The epidemiology of ETEC diarrhea among children living in a rural Egyptian community was further evaluated in this study. Between January 2004 and April 2007, 348 neonates were enrolled and followed for 2 years. Children were visited twice weekly, and a stool sample was obtained every 2 weeks regardless of symptomatology. A stool sample was obtained whenever a child had diarrhea. From the routine stool culture, five E. coli-like colonies were selected and screened for heat-labile and heat-stable toxins by GM1 enzyme-linked immunosorbent assay (ELISA) and further typed for colonization factor antigens by dot blot assay. Incidence of ETEC infection was estimated among children with diarrhea (symptomatic) and without diarrhea (asymptomatic). Incidence of diarrhea and ETEC-associated diarrhea was 7.8 and 1.48 per child-year, respectively. High risk of repeated ETEC diarrhea was associated with being over 6 months of age, warm season, male gender, and crowded sleeping conditions. Exclusive breast-feeding was protective for repeated ETEC infection. ETEC-associated diarrhea remains common among children living in the Nile Delta. The protective role of breast-feeding demonstrates the importance of promoting exclusive breast-feeding during, at least, the first 6 months of life.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829232      PMCID: PMC4097688          DOI: 10.1128/JCM.00215-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Magnitude and impact of diarrheal diseases.

Authors:  Richard L Guerrant; Margaret Kosek; Sean Moore; Breyette Lorntz; Richard Brantley; Aldo A M Lima
Journal:  Arch Med Res       Date:  2002 Jul-Aug       Impact factor: 2.235

2.  Asymptomatic infections by diarrheagenic Escherichia coli in children from Misiones, Argentina, during the first twenty months of their lives.

Authors:  M Quiroga; P Oviedo; I Chinen; E Pegels; E Husulak; N Binztein; M Rivas; L Schiavoni; M Vergara
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2000 Jan-Feb       Impact factor: 1.846

3.  Human colostral phagocytes eliminate enterotoxigenic Escherichia coli opsonized by colostrum supernatant.

Authors:  Eduardo Luzía França; Renata Vieira Bitencourt; Mahmi Fujimori; Tassiane Cristina de Morais; Iracema de Mattos Paranhos Calderon; Adenilda Cristina Honorio-França
Journal:  J Microbiol Immunol Infect       Date:  2011-01-12       Impact factor: 4.399

4.  Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study.

Authors:  Douglas S Berkman; Andres G Lescano; Robert H Gilman; Sonia L Lopez; Maureen M Black
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

5.  Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin.

Authors:  A M Svennerholm; G Wiklund
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

6.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Authors:  Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2012-05-11       Impact factor: 79.321

7.  Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method.

Authors:  John Clemens; Stephen Savarino; Remon Abu-Elyazeed; Mohammad Safwat; Malla Rao; Thomas Wierzba; Ann-Marie Svennerholm; Jan Holmgren; Robert Frenck; Eunsik Park; Abdollah Naficy
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

8.  High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children.

Authors:  Malla R Rao; Remon Abu-Elyazeed; Stephen J Savarino; Abdollah B Naficy; Thomas F Wierzba; Ibrahim Abdel-Messih; Hind Shaheen; Robert W Frenck; Ann-Mari Svennerholm; John D Clemens
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  Phenotypic and genotypic analysis of enterotoxigenic Escherichia coli in samples obtained from Egyptian children presenting to referral hospitals.

Authors:  H I Shaheen; I A Abdel Messih; J D Klena; A Mansour; Z El-Wakkeel; T F Wierzba; J W Sanders; S B Khalil; D M Rockabrand; M R Monteville; P J Rozmajzl; A M Svennerholm; R W Frenck
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948

10.  Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh.

Authors:  F Qadri; S K Das; A S Faruque; G J Fuchs; M J Albert; R B Sack; A M Svennerholm
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

View more
  4 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

2.  Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.

Authors:  Aisling O'Dowd; Milton Maciel; Steven T Poole; Michael G Jobling; Julianne E Rollenhagen; Colleen M Woods; Stephanie A Sincock; Annette L McVeigh; Michael J Gregory; Ryan C Maves; Michael G Prouty; Randall K Holmes; Stephen J Savarino
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

3.  Anti-diarrhea activity of the aqueous root bark extract of Byrsocarpus coccineus on castor oil-induced diarrhea in Wistar rats.

Authors:  Sunday A Ejeh; Patrick Onyeyili; Samson E Abalaka
Journal:  Vet World       Date:  2017-07-05

4.  Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study.

Authors:  Marta Olivares; Alfonso Benítez-Páez; Giada de Palma; Amalia Capilla; Esther Nova; Gemma Castillejo; Vicente Varea; Ascensión Marcos; José Antonio Garrote; Isabel Polanco; Ester Donat; Carmen Ribes-Koninckx; Carmen Calvo; Luis Ortigosa; Francesc Palau; Yolanda Sanz
Journal:  Gut Microbes       Date:  2018-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.